Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer
Document Type
Journal Article
Publication Date
7-2013
Journal
Clinical Oncology Alert
Volume
Volume 29, Issue 7
Inclusive Pages
51
APA Citation
Kanani, S.P. (2013). Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Clinical Oncology Alert, 29(7), 51.
Peer Reviewed
1
COinS